Drug Database
Back to search

Netherlands· NL-37ed2b24e990

Beriplex P/N 1000 IE, poeder en oplosmiddel voor oplossing voor injectie

A coagulation factor ix, ii, vii and x in combination product containing factor ii, humaan + factor ix, humaan + factor vii, humaan + factor x, humaan, registered in Netherlands by CSL Behring GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC B02BD01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedBeriplex P/N 1000 IE, poeder en oplos…ATCB02BD01REGISTER NO.NL-37ed2b24e990PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about factor ii, humaan + factor ix, humaan + factor vii, humaan + factor x, humaanAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Coagulation factor ix, ii, vii and x in combination is registered in 11 of 19 countries.

Countries holding a registration under ATC B02BD01 (coagulation factor ix, ii, vii and x in combination), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search coagulation factor ix, ii, vii and x in combination products by name

Coagulation factor ix, ii, vii and x in combination · ATC B02BD01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
FACTOR II, HUMAAN + FACTOR IX, HUMAAN + FACTOR VII, HUMAAN + FACTOR X, HUMAAN
Manufacturer
CSL Behring GmbH
Country
Netherlands (NL)
ATC code
B02BD01
ATC class
Coagulation factor IX, II, VII and X in combination
Defined daily dose
1.6 TSD, E
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    112293

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for coagulation factor ix, ii, vii and x in combination.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check coagulation factor ix, ii, vii and x in combination against other medicinesHow interaction checks work

Coagulation factor ix, ii, vii and x in combination · interactions on record

3 records

  • 2 severe
  • 1 moderate

Most severe, free to view

  • CarfilzomibL01XG02severe
  • CarfilzomibL01XX45severe
  • PegvaliaseA16AB19moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under B02BD01

Coagulation factor ix, ii, vii and x in combination, as other registers publish it.

All coagulation factor ix, ii, vii and x in combination products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a57e76ad-c5a5-4e98-8e20-3c4854fba776
GET /v1/drugs/a57e76ad-c5a5-4e98-8e20-3c4854fba776?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder en oplosmiddel voor oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h112293_smpc.pdf",
  "strength": null,
  "atc_label": "Coagulation Factor IX, II, VII And X In Combination",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg112293",
  "excipients": [
    "ANTITROMBINE III",
    "HEPARINE NATRIUM",
    "HUMAAN ALBUMINE",
    "NATRIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "TRINATRIUMCITRAAT 2-WATER (E 331)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "FACTOR II, HUMAAN",
    "FACTOR IX, HUMAAN",
    "FACTOR VII, HUMAAN",
    "FACTOR X, HUMAAN",
    "PROTEÏNE C, HUMAAN",
    "PROTEÏNE S, HUMAAN"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h112293.pdf",
  "authorised_at": "2013/03/20",
  "procedure_number": "DE/H/0477/003",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "112293",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about coagulation factor ix, ii, vii and x in combination.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console